Nov 2 (Reuters) - Castle Biosciences Inc CSTL.O :
* CASTLE BIOSCIENCES ANNOUNCES THIRD QUARTER 2022 RESULTS
* SEES FY REVENUE $255.0 MILLION TO $330.0 MILLION
* QTRLY REVENUES WERE $37.0 MILLION, A 58% INCREASE COMPARED
TO
$23.5 MILLION DURING SAME PERIOD IN 2021
* NET LOSS FOR Q3 WAS $20.2 MILLION, COMPARED TO $11.8
MILLION FOR
SAME PERIOD IN 2021
* Q3 REVENUE VIEW $34.8 MILLION -- REFINITIV IBES DATA
* FY2022 REVENUE VIEW $132.3 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw9dqc6Pa
Further company coverage: CSTL.O
((Reuters.Briefs@thomsonreuters.com;))